Giapreza 2.5 mg/ml concentrate for solution for infusion, SODIUM CHLORIDE SOLUTION 0.9% clinical trials

A phase III randomised, double-blind, placebo-controlled, multicentre efficacy and safety clinical trial of angiotensin II in paediatric patients of 0 to 17 years of age with refractory hypotension in distributive shock receiving fluid resuscitation and standard-of-care vasopressors

This study is looking at a new medicine called angiotensin II for very sick children (0-17 years old) who have very low blood pressure due to a serious infection or illness (distributive shock). It aims to see if this medicine can help reduce the need for other strong blood pressure support drugs.